Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H N Sather

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Medical and Pediatric Oncology|January 1, 1984
Mediastinal mass in acute lymphoblastic leukemiaR R Chilcote, P Coccia, H N Sather, et al.
Leukemia|June 22, 1999
Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosis of infants with t(4;11) - a report of the Children's Cancer GroupN A Heerema, H N Sather, J Ge, et al.
Leukemia|May 1, 1994
Epidemiological characteristics of childhood acute lymphocytic leukemia. Analysis by immunophenotype. The Childrens Cancer GroupJ D Buckley, C M Buckley, K Ruccione, et al.
Lancet (London, England)|February 28, 1981
Presymptomatic central nervous system therapy in previously untreated childhood acute lymphoblastic leukaemia: comparison of 1800 rad and 2400 rad. A report for Children's Cancer Study GroupM E Nesbit, H N Sather, L L Robison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1993
Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group reportD G Tubergen, G S Gilchrist, R T O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1993
Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trialD G Tubergen, G S Gilchrist, R T O'Brien, et al.
Leukemia|February 24, 2001
Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995P S Gaynon, M E Trigg, N A Heerema, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia: a Childrens Cancer Group reportG S Gilchrist, D G Tubergen, H N Sather, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study GroupD R Miller, P F Coccia, W A Bleyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer GroupJ Nachman, H N Sather, J M Cherlow, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Medical and Pediatric Oncology|January 1, 1984
Mediastinal mass in acute lymphoblastic leukemiaR R Chilcote, P Coccia, H N Sather, et al.
Leukemia|June 22, 1999
Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosis of infants with t(4;11) - a report of the Children's Cancer GroupN A Heerema, H N Sather, J Ge, et al.
Leukemia|May 1, 1994
Epidemiological characteristics of childhood acute lymphocytic leukemia. Analysis by immunophenotype. The Childrens Cancer GroupJ D Buckley, C M Buckley, K Ruccione, et al.
Lancet (London, England)|February 28, 1981
Presymptomatic central nervous system therapy in previously untreated childhood acute lymphoblastic leukaemia: comparison of 1800 rad and 2400 rad. A report for Children's Cancer Study GroupM E Nesbit, H N Sather, L L Robison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1993
Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group reportD G Tubergen, G S Gilchrist, R T O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1993
Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trialD G Tubergen, G S Gilchrist, R T O'Brien, et al.
Leukemia|February 24, 2001
Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995P S Gaynon, M E Trigg, N A Heerema, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia: a Childrens Cancer Group reportG S Gilchrist, D G Tubergen, H N Sather, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study GroupD R Miller, P F Coccia, W A Bleyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer GroupJ Nachman, H N Sather, J M Cherlow, et al.
Pageof 9